Cetuximab Completed Phase 1 Trials for Neoplasms Metastasis / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00522886Phase I Cetuximab and Concurrent Radio-chemotherapy
NCT00162318A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
NCT01090011Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
NCT00207116An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma